Please select the option that best describes you:

How would you manage a middle-aged patient with Paget's disease who received one dose of zolendronic acid 2 years ago, currently suppressed CTX, normal bone-specific Alkaline phos, and a recent hairline fracture in the thoracic spine?  

Is there any data on the use of anabolic agents in Paget's disease?



Answer from: at Academic Institution

Answer from: at Academic Institution